Cigarette & Tobacco Manufacturing in the US - Market Research Report (2014-2029)

Decades of information have drilled the negative health impacts of regular tobacco use into much of the public's mind, causing fewer and fewer younger consumers to pick up the habit and the percentage of smokers to steadily sink. But that doesn't mean sales have steadily sunk. Cigarette and tobacco manufacturers perform countercyclically to the business cycle, benefitting from nicotine, a naturally occurring chemical in tobacco that provides users with a sense of calm and one of the most addictive substances documented. Sales boosted during the pandemic's peak, as heightened uncertainty and isolation drove many to seek chemical comfort, but slumped as social-distancing measures eased and consumers returned to daily life. The dichotomy between tobacco's known health detriments and nicotine's highly addictive nature imbues the industry with inherent volatility. Revenue has been expanding at a CAGR of 0.5% and is expected to reach $57.8 billion in 2024 when sales will slip 1.3%.